The U.S. Food and Drug Administration said on Friday it has approved the use of a drug combination along with Sanofi's ...

Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a progressive form of the ...

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Sanofi (SNYNF – Research Report) today and set a price target of €100.00.

Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price ...

However, neither DRC nor other African nations produce the vaccines that could slow the spread of mpox and eventually help it ...

The 24,000m² facility can reconfigure rapidly for the production of up to four different products simultaneously.

A French pharmaceutical company has been trying to stop a proposed condo development near its Toronto campus by arguing that ...

Adult Vaccine Market Adult Vaccine Market Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Report, ...

It can be republished for free. The new vaccine should provide some protection to everyone. But many healthy people who have already been vaccinated or have immunity because they’ve been exposed to ...

As updated coronavirus vaccines hit U.S. pharmacy shelves, adults without health insurance are discovering the shots are no longer free, instead costing up to $200. The federal Bridge Access ...

Pneumococcal Vaccine Market” from 2024-2034 with covered segments By Vaccine Type (Pneumococcal Conjugate Vaccine and Pneumococcal Polysaccharide Va ...

The po­ten­tial of Sanofi’s close­ly-watched BTK in­hibitor in mul­ti­ple scle­ro­sis is com­ing in­to clear­er view amid plans to nar­row the fo­cus of the French com­pa­ny’ … ...